These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6967756)

  • 21. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors.
    Kudo-Saito C; Schlom J; Camphausen K; Coleman CN; Hodge JW
    Clin Cancer Res; 2005 Jun; 11(12):4533-44. PubMed ID: 15958639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression and restoration of cytotoxic T-cell activity during chemotherapy of a mouse T-cell lymphoma and a macrophage tumor.
    Tarnowski GS; Faanes RB; Ralph P; Williams N
    Cancer Res; 1978 Dec; 38(12):4540-5. PubMed ID: 309790
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interleukin 2].
    Voĭtenok NN
    Ter Arkh; 1988; 60(5):42-6. PubMed ID: 3051488
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-dependent cellular cytotoxicity mediated by polymorphonuclear leukocytes.
    Ikenami M; Mizuno D; Yamazaki M
    Jpn J Cancer Res; 1985 Jul; 76(7):637-43. PubMed ID: 3928561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928).
    Wheeler GP; Bowdon BJ; Werline JA; Adamson DJ; Temple CG
    Cancer Res; 1982 Mar; 42(3):791-8. PubMed ID: 7059977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunostimulation by Alsophila spinulosa extract fraction VII of both humoral and cellular immune responses.
    Kao SF; Kuo HL; Lee YC; Chiang HC; Lin YS
    Anticancer Res; 1994; 14(6B):2439-43. PubMed ID: 7872664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of inhibitor-antioxidant of 3-hydroxypyridine series on cellular immunity].
    Suzdal'tseva AA; Kapichnikov MM; Shalyminova IuA; Zykov IuV; Smirnov LD
    Biull Eksp Biol Med; 1982 Feb; 93(2):49-50. PubMed ID: 7066526
    [No Abstract]   [Full Text] [Related]  

  • 33. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
    Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
    Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 36. Proliferation-dependent cytotoxicity of anticancer agents: a review.
    Valeriote F; van Putten L
    Cancer Res; 1975 Oct; 35(10):2619-30. PubMed ID: 1098765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correction of anti-tumor immunity by beta-carotene during experimental chemotherapy of malignant neoplasms].
    Ramanauskaĭte RIu; Abronina IF; Karaseva LI; Sergeev AV
    Biull Eksp Biol Med; 1994 Sep; 118(9):295-7. PubMed ID: 7819566
    [No Abstract]   [Full Text] [Related]  

  • 40. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.